Vertex Pharmaceuticals Aktie WKN: 882807 / ISIN: US92532F1003

259,00EUR
+3,40EUR
+1,33%
291,10USD
+4,82USD
+1,68%
Diese Aktie kaufen
Werbung
mehr Daten anzeigen

Vertex Pharmaceuticals Aktie Analyse

01.08.19 Vertex Pharmaceuticals Hold Needham & Company, LLC
06.02.19 Vertex Pharmaceuticals Hold Maxim Group
26.10.18 Vertex Pharmaceuticals Buy H.C. Wainwright & Co.
01.10.18 Vertex Pharmaceuticals Overweight Cantor Fitzgerald
07.08.18 Vertex Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
05.03.18 Vertex Pharmaceuticals Buy Maxim Group
01.02.18 Vertex Pharmaceuticals overweight Barclays Capital
18.10.17 Vertex Pharmaceuticals Outperform RBC Capital Markets
Werbung
29.09.17 Vertex Pharmaceuticals Buy BTIG Research
15.09.17 Vertex Pharmaceuticals Outperform RBC Capital Markets
19.07.17 Vertex Pharmaceuticals overweight Barclays Capital
18.07.17 Vertex Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
23.06.17 Vertex Pharmaceuticals Buy Needham & Company, LLC
31.03.17 Vertex Pharmaceuticals Outperform BMO Capital Markets
31.03.17 Vertex Pharmaceuticals Buy Maxim Group
29.03.17 Vertex Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
09.03.17 Vertex Pharmaceuticals Buy UBS AG
26.01.17 Vertex Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
24.10.16 Vertex Pharmaceuticals Neutral H.C. Wainwright & Co.
15.09.16 Vertex Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
28.04.16 Vertex Pharmaceuticals overweight Barclays Capital
28.04.16 Vertex Pharmaceuticals Outperform RBC Capital Markets
08.04.16 Vertex Pharmaceuticals Market Perform BMO Capital Markets
01.04.16 Vertex Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
18.03.16 Vertex Pharmaceuticals Outperform RBC Capital Markets
01.12.15 Vertex Pharmaceuticals Buy Stifel, Nicolaus & Co., Inc.
30.10.15 Vertex Pharmaceuticals Buy H.C. Wainwright & Co.
28.09.15 Vertex Pharmaceuticals Buy Argus Research Company
14.09.15 Vertex Pharmaceuticals overweight Barclays Capital
23.06.15 Vertex Pharmaceuticals Outperform RBC Capital Markets
10.04.15 Vertex Pharmaceuticals Buy Canaccord Adams
29.01.15 Vertex Pharmaceuticals Buy Deutsche Bank AG
29.01.15 Vertex Pharmaceuticals Hold Maxim Group
29.01.15 Vertex Pharmaceuticals Hold Needham & Company, LLC
01.12.14 Vertex Pharmaceuticals Buy Maxim Group
06.11.14 Vertex Pharmaceuticals Buy CRT Capital
29.10.14 Vertex Pharmaceuticals Outperform RBC Capital Markets
10.10.14 Vertex Pharmaceuticals Buy Maxim Group
17.09.14 Vertex Pharmaceuticals Buy Deutsche Bank AG
14.12.12 Vertex Pharmaceuticals sell Goldman Sachs Group Inc.
05.12.12 Vertex Pharmaceuticals outperform RBC Capital Markets
13.11.12 Vertex Pharmaceuticals neutral Credit Suisse Group
05.11.12 Vertex Pharmaceuticals sell Goldman Sachs Group Inc.
02.11.12 Vertex Pharmaceuticals buy UBS AG
02.11.12 Vertex Pharmaceuticals outperform RBC Capital Markets
12.10.12 Vertex Pharmaceuticals outperform RBC Capital Markets
13.09.12 Vertex Pharmaceuticals outperform RBC Capital Markets
30.08.12 Vertex Pharmaceuticals outperform RBC Capital Markets
02.08.12 Vertex Pharmaceuticals buy Banc of America Securities-Merrill Lynch
01.08.12 Vertex Pharmaceuticals neutral Piper Jaffray & Co.
Seite: 1 | 2 | 3 | 4

Analysensuche

GO
Werbung

Aktuelle News zu

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln